Financhill
Back

HIVE Digital Technologies Vs. Xtacy Therapeutics Industry Stock Comparison

Sell
36

HIVE.V
HIVE Digital Technologies

Last Price:
4.26
Seasonality Move:
12.04%
Sell
20

XTCY.CX
Xtacy Therapeutics

Last Price:
0.02
Seasonality Move:
43.46%
Sell
36
HIVE Digital Technologies (HIVE.V) is a Sell

Is HIVE Digital Technologies a Buy, Sell or Hold?

  • The current HIVE Digital Technologies [HIVE.V] share price is $4.06. The Score for HIVE.V is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • HIVE.V is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Xtacy Therapeutics (XTCY.CX) is a Sell

Is Xtacy Therapeutics a Buy, Sell or Hold?

  • The current Xtacy Therapeutics [XTCY.CX] share price is $0.02. The Score for XTCY.CX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • XTCY.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

HIVE.V Stock Price Chart

What is HIVE Digital Technologies's stock price today?

  • The HIVE Digital Technologies share price today is $4.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIVE.V is experiencing selling pressure, which indicates risk of future bearish movement.

XTCY.CX Stock Price Chart

What is Xtacy Therapeutics's stock price today?

  • The Xtacy Therapeutics share price today is $0.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing slight buying pressure.

HIVE.V Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 47.86 Sell
Chaikin Money Flow: -570428 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.82 - 4.42) Sell
Bollinger Bands (100): (3.49 - 4.79) Sell

XTCY.CX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 38.74 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.02 - 0.04) Sell
Bollinger Bands (100): (0.03 - 0.05) Sell

HIVE.V Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.04 Buy
20-day SMA: 4.14 Sell
50-day SMA: 4.48 Sell
200-day SMA: 4.48 Sell
8-day EMA: 4.05 Buy
20-day EMA: 4.1 Sell
50-day EMA: 4.24 Sell
200-day EMA: 4.4 Sell

XTCY.CX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.03 Sell
20-day SMA: 0.03 Sell
50-day SMA: 0.04 Sell
200-day SMA: 0.04 Sell
8-day EMA: 0.03 Sell
20-day EMA: 0.03 Sell
50-day EMA: 0.03 Sell
200-day EMA: 0.05 Sell

HIVE Digital Technologies Earnings Growth & HIVE.V Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

HIVE Digital Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Xtacy Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):